Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kerecis Ltd.

This article was originally published in Start Up

Executive Summary

The Marigen Lipid Enhanced Matrix from Kerecis Ltd. is derived from fish skin and has been shown to effectively improve the healing of wounds and surgical cuts. The company says that Marigen offers significant advantages over existing human and porcine-derived products, including improved manufacturing economics, lower risk of disease transfer and the promise of better clinical outcomes.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT037682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel